ÂÜÀòÂÒÂ×

Ronald Krasnow, J.D., brings over 30 years of legal counsel and executive management experience to T-knife. Previously, Mr. Krasnow was the Chief Operating Officer of Arch Oncology, a company dedicated to antibody therapies for the treatment of cancer. Previously, he was General Counsel, Secretary and Chief Compliance Officer at Menlo Therapeutics. Prior to Menlo, he served as Senior Vice President, General Counsel and Secretary of Relypsa, Inc. At Relypsa, he helped the company grow from start-up, through IPO, commercialization and acquisition as it invented, developed and marketed Veltassa, the first new drug to treat hyperkalemia approved by the FDA in more than 50 years. Earlier in his career, he focused on intellectual property and was at Symyx Technologies, Inc. where he spent 10 years in various positions, including Senior Vice President of Intellectual Property. Prior to Symyx, he was an attorney at Fish & Neave representing clients in complex patent litigation and interferences. He has also been a patent examiner at the U.S. Patent and Trademark Office. He holds a B.S. in Materials and Metallurgical Engineering from The University of Michigan and a J.D. from The George Washington University Law School. He is admitted to practice in California, New York and the U.S. Patent and Trademark Office.